Melatonin protects from the long-term consequences of a neonatal hypoxic-ischemic brain injury in rats

Journal of Pineal Research

Volumn 44, Issue 2, 2008, Pages 157-164

  Carloni, Silvia ^a   Perrone, Serafina ^b   Buonocore, Giuseppe ^b   Longini, Mariangela ^b   Proietti, Fabrizio ^b   Balduini, Walter ^a  

^a UNIVERSITY OF URBINO   (Italy)

^b UNIVERSITY OF SIENA   (Italy)

Author keywords

Behavior; Free radical scavenger; Hypoxia ischemia; Melatonin; Neuroprotection; Newborn rats

Indexed keywords

MELATONIN;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN INJURY; BRAIN ISCHEMIA; COMMON CAROTID ARTERY; CONTROLLED STUDY; DOSE RESPONSE; DRUG SAFETY; GROWTH RATE; HISTOLOGY; LEARNING DISORDER; NEUROPROTECTION; NEWBORN HYPOXIA; NONHUMAN; RAT;

ANIMALS; ANIMALS, NEWBORN; DISEASE MODELS, ANIMAL; FEMALE; HYPOXIA-ISCHEMIA, BRAIN; MELATONIN; RATS; RATS, SPRAGUE-DAWLEY;

EID: 39149129341     PISSN: 07423098     EISSN: 1600079X     Source Type: Journal    
DOI: 10.1111/j.1600-079X.2007.00503.x     Document Type: Article

References (44)

1. Vannucci RC. Hypoxic-ischemic encephalopathy. Am J Perinatol 2000 17 : 113 120.
2. Volpe JJ. Perinatal brain injury: from pathogenesis to neuroprotection. Ment Retard Dev Disabil Res Rev 2001 7 : 56 64.
3. Aylward GP. Cognitive and neuropsychological outcomes: more than IQ scores. Ment Retard Dev Disabil Res Rev 2002 8 : 234 240.
4. Bhutta AT, Anand KJ. Vulnerability of the developing brain. Neuronal mechanisms. Clin Perinatol 2002 29 : 357 372.
5. Pleacher MD, Vohr BR, Katz KH et al. An evidence-based approach to predicting low IQ in very preterm infants from the neurological examination: outcome data from the indomethacin Indomethacin Intraventricular Hemorrhage Prevention Trial. Pediatrics 2004 113 : 416 419.
6. Vohr BR, Wright LL, Dusick AM et al. Neurodevelopmental and functional outcomes of extremely low birth weight infants in the National Institute of Child Health and Human Development Neonatal Research Network, 1993-1994. Pediatrics 2000 105 : 1216 1226.
7. Kadhim H, Sebire G, Khalifa M et al. Incongruent cerebral growth in sudden infant death syndrome. J Child Neurol 2005 20 : 244 246.
8. Balduini W, Carloni S, Mazzoni E et al. New therapeutic strategies in perinatal stroke. Curr Drug Targets CNS Neurol Disord 2004 3 : 315 323.
9. Bracci R, Buonocore G. Chorioamnionitis: a risk factor for fetal and neonatal morbidity. Biol Neonate 2003 83 : 85 96.
10. Mclean C, Ferriero D. Mechanisms of hypoxic-ischemic injury in the term infant. Semin Perinatol 2004 28 : 425 432.
11. Rosen J, Than NN, Koch D et al. Interactions of melatonin and its metabolites with the ABTS cation radical: extension of the radical scavenger cascade and formation of a novel class of oxidation products, C2-substituted 3-indolinones. J Pineal Res 2006 41 : 374 381.
12. Tan DX, Manchester LC, Terron MP et al. One molecule, many derivatives: a never-ending interaction of melatonin with reactive oxygen and nitrogen species? J Pineal Res 2007 42 : 28 42.
13. Rodriguez C, Mayo JC, Sainz RM et al. Regulation of antioxidant enzymes: a significant role for melatonin. J Pineal Res 2004 36 : 1 9.
14. Tomas-Zapico C, Coto-Montes A. A proposed mechanism to explain the stimulatory effect of melatonin on antioxidative enzymes. J Pineal Res 2005 39 : 99 104.
15. Cuzzocrea S, Reiter RJ. Pharmacological action of melatonin in shock, inflammation and ischemia/reperfusion injury. Eur J Pharmacol 2001 426 : 1 10.
16. Reiter RJ, Tan DX, Terron MP et al. Melatonin and its metabolites: new findings regarding their production and their radical scavenging actions. Acta Biochim Pol 2007 54 : 1 9.
17. Cheung RT. The utility of melatonin in reducing cerebral damage resulting from ischemia and reperfusion. J Pineal Res 2003 34 : 153 160.
18. Pei Z, Pang SF, Cheung RT. Administration of melatonin after onset of ischemia reduces the volume of cerebral infarction in a rat middle cerebral artery occlusion stroke model. Stroke 2003 34 : 770 775.
19. Reiter RJ, Tan DX, Gitto E et al. Pharmacological utility of melatonin in reducing oxidative cellular and molecular damage. Pol J Pharmacol 2004 56 : 159 170.
20. Deng WG, Tang ST, Tseng HP et al. Melatonin suppresses macrophage cyclooxygenase-2 and inducible nitric oxide synthase expression by inhibiting p52 acetylation and binding. Blood 2006 108 : 518 524.
21. Gitto E, Karbownik M, Reiter RJ et al. Effects of melatonin treatment in septic newborns. Pediatr Res 2001 50 : 756 760.
22. Gitto E, Reiter RJ, Amodio A et al. Early indicators of chronic lung disease in preterm infants with respiratory distress syndrome and their inhibition by melatonin. J Pineal Res 2004 36 : 250 255.
23. Fulia F, Gitto E, Cuzzocrea S et al. Increased levels of malondialdehyde and nitrite/nitrate in the blood of asphyxiated newborns: reduction by melatonin. J Pineal Res 2001 31 : 343 349.
24. Rice JE III., Vannucci RC, Brierley JB. The influence of immaturity on hypoxic-ischemic brain damage in the rat. Ann Neurol 1981 9 : 131 141.
25. Balduini W, Mazzoni E, Carloni S et al. Prophylactic but not delayed administration of simvastatin protects against long-lasting cognitive and morphological consequences of neonatal hypoxic-ischemic brain injury, reduces interleukin-1beta and tumor necrosis factor-alpha mRNA induction, and does not affect endothelial nitric oxide synthase expression. Stroke 2003 34 : 2007 2012.
26. Balduini W, De Angelis V, Mazzoni E et al. Long-lasting behavioral alterations following a hypoxic/ischemic brain injury in neonatal rats. Brain Res 2000 859 : 318 325.
27. Balduini W, De Angelis V, Mazzoni E et al. Simvastatin protects against long-lasting behavioral and morphological consequences of neonatal hypoxic/ischemic brain injury. Stroke 2001 32 : 2185 2191.
28. Pei Z, Ho HT, Cheung RT. Pre-treatment with melatonin reduces volume of cerebral infarction in a permanent middle cerebral artery occlusion stroke model in the rat. Neurosci Lett 2002 318 : 141 144.
29. Pei Z, Pang SF, Cheung RT. Pretreatment with melatonin reduces volume of cerebral infarction in a rat middle cerebral artery occlusion stroke model. J Pineal Res 2002 32 : 168 172.
30. Geddes R, Vannucci RC, Vannucci SJ. Delayed cerebral atrophy following moderate hypoxia-ischemia in the immature rat. Dev Neurosci 2001 23 : 180 185.
31. Macleod MR, O'Collins T, Horky LL et al. Systematic review and meta-analysis of the efficacy of melatonin in experimental stroke. J Pineal Res 2005 38 : 35 41.
32. Giusti P, Gusella M, Lipartiti M et al. Melatonin protects primary cultures of cerebellar granule neurons from kainate but not from N-methyl-D-aspartate excitotoxicity. Exp Neurol 1995 131 : 39 46.
33. Husson I, Mesples B, Bac P et al. Melatoninergic neuroprotection of the murine periventricular white matter against neonatal excitotoxic challenge. Ann Neurol 2002 51 : 82 92.
34. Watanabe K, Wakatsuki A, Shinohara K et al. Maternally administered melatonin protects against ischemia and reperfusion-induced oxidative mitochondrial damage in premature fetal rat brain. J Pineal Res 2004 37 : 276 280.
35. Welin AK, Svedin P, Lapatto R et al. Melatonin reduces inflammation and cell death in white matter in the mid-gestation fetal sheep following umbilical cord occlusion. Pediatr Res 2007 61 : 153 158.
36. Ozdemir D, Tugyan K, Uysal N et al. Protective effect of melatonin against head trauma-induced hippocampal damage and spatial memory deficits in immature rats. Neurosci Lett 2005 385 : 234 239.
37. Mayo JC, Sainz RM, Tan DX et al. Anti-inflammatory actions of melatonin and its metabolites, N1-acetyl-N2-formyl-5-methoxykynuramine (AFMK) and N1-acetyl-5-methoxykynuramine (AMK), in macrophages. J Neuroimmunol 2005 165 : 139 149.
38. Mohan N, Sadeghi K, Reiter RJ et al. The neurohormone melatonin inhibits cytokine, mitogen and ionizing radiation induced NF-kappa B. Biochem Mol Biol Int 1995 37 : 1063 1070.
39. Cuzzocrea S, Reiter RJ. Pharmacological actions of melatonin in acute and chronic inflammation. Curr Top Med Chem 2002 2 : 153 165.
40. Leon J, Acuna-Castroviejo D, Escames G et al. Melatonin mitigates mitochondrial malfunction. J Pineal Res 2005 38 : 1 9.
41. Saugstad OD. Mechanisms of tissue injury by oxygen radicals: implications for neonatal disease. Acta Paediatr 1996 85 : 1 4.
42. Carloni S, Carnevali A, Cimino M et al. Extended role of necrotic cell death after hypoxia-ischemia-induced neurodegeneration in the neonatal rat. Neurobiol Dis 2007 (doi:).
43. Northington FJ, Graham EM, Martin LJ. Apoptosis in perinatal hypoxic-ischemic brain injury: how important is it and should it be inhibited? Brain Res Brain Res Rev 2005 50 : 244 257.
44. Pandi-Perumal SR, Srinivasan V, Maestroni GJ et al. Melatonin: nature's most versatile biological signal? Febs J 2006 273 : 2813 2838.